TRAF2 and hepatocellular carcinoma: The latest research further showed that TRAF2 deficiency increases ROMO1 expression and stimulate the NAD + /SIRT3/SOD2 signaling pathway to promote the ROS production of HCC cells and its mitochondrial dysfunction [31].